Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Platelet-Associated Antibodies By Flow Cytometry in Adult Patients with Immune Thrombocytopenia before and after Splenectomy

Kseniya A. Nikiforova, Elena K. Egorova, MD PhD, Yuliya O. Davydova, Nikolay M. Kapranov, Elena I. Pustovaya, MD PhD, Olga A. Soboleva, Irina V. Galtseva, MD PhD, Anait L. Melikyan, MD PhD, Karen I. Ntanisian, MD PhD, Valeriy G. Savchenko, MD PhD

Blood (2020) 136 (Supplement 1): 4–5.

https://doi.org/10.1182/blood-2020-140945

Published: 2020

Journal Articles

Oligoclonal Expansion and T-Cells Subpopulations in Patients with Aplastic Anemia at Different Stages of the Disease

Anastasia V. Abramova, MD, Elena A. Mikhaylova, MD PhD Prof, Zalina T. Fidarova, MD PhD, Yuliya O. Davydova, Nikolay M. Kapranov, Tatiana I. Lobanova, MD, Anton V. Luchkin, MD, Alina E. Krasilnikova, Resident Physician, Roman V. Tivikov, MD, Vera V. Troitskaya, MD PhD, Irina V. Galtseva, PhD, Elena N. Parovichnikova, MD PhD, Valery G. Savchenko, MD PhD academician

Blood (2018) 132 (Supplement 1): 3864.

https://doi.org/10.1182/blood-2018-99-119414

Published: 2018

Journal Articles

The Effectiveness of Eltrombopag at the Different Stages of Aplastic Anemia and Probability of Clonal Expansion

Anton V. Luchkin, MD, Elena A. Mikhaylova, MD PhDProf, Zalina T. Fidarova, MD PhD, Anastasia V. Abramova, MD, Vera V. Troitskaya, MD PhD, Tatiana I. Lobanova, MD, Alina E. Krasilnikova, Resident Physician, Irina V. Galtseva, PhD, Yuliya O. Davydova, Nikolay M. Kapranov, Tatiana N. Obukhova, MD PhD, Lubov Grebenyuk, MD, Murat Vagida, MD, Elena N. Parovichnikova, MD PhD, Valery G. Savchenko, MD PhD academician

Blood (2018) 132 (Supplement 1): 5108.

https://doi.org/10.1182/blood-2018-99-118738

Published: 2018

Journal Articles

Different Treatment Regimens, Optimal Time Points and Threshold Level While Minimal Residual Disease Evaluation in AML Patients

Tatiana I. Lobanova, MD, Irina V. Galtseva, PhD, Yuliya O. Davydova, Nikolay M. Kapranov, Vera V. Troitskaya, MD PhD, Irina A. Lukyanova, MD, Elena Parovichnikova, MD PhD, Sergei M. Kulikov, PhD, Larisa Kuzmina, PhD, Valery G. Savchenko, MD PhD academician

Blood (2018) 132 (Supplement 1): 2808.

https://doi.org/10.1182/blood-2018-99-114669

Published: 2018

Journal Articles

The MRD-Negativity Rate Measured By Flow Cytometry after the 1 st and the 2 nd Induction Course Among CR AML Patients from Different Cytogenetic Subgroups Does Not Differ Though the Morphological CR Achievement Does

Elena Parovichnikova, MD PhD, Vera V. Troitskaya, MD PhD, Irina V. Galtseva, PhD, Tatiana I. Lobanova, MD, Yuliya O. Davydova, Nikolay M. Kapranov, Andrey N. Sokolov, MD, Alina V. Kokhno, MD, PhD, Roman V. Tivikov, MD, Irina A. Lukyanova, MD, Tatiana N. Obukhova, MD PhD, Valery G. Savchenko, MD PhD academician

Blood (2018) 132 (Supplement 1): 1495.

https://doi.org/10.1182/blood-2018-99-116581

Published: 2018

Journal Articles

Effective and Ineffective Samples of Mesenchymal Multipotent Stromal Cells Used for Acute Graft-Versus-Host Disease Prophylaxis after Allogeneic Bone Marrow Transplantation Differ in the Expression Level of HLA-DR When Co-Cultured with Activated Lymphocytes

Nataliya Petinati, PhD MD, Nikolay M. Kapranov, Yuliya O Davydova, Alexey Bigildeev, PhD, Natalia Sats, PhD, Irina Shipounova, PhD, Nina Drize, PhD, Irina V. Galtseva, MD PhD, Larisa A. Kuzmina, MD PhD, Elena N. Parovichnikova, MD PhD, Valeriy G. Savchenko

Blood (2017) 130 (Supplement 1): 5494.

https://doi.org/10.1182/blood.V130.Suppl_1.5494.5494

Published: 2017

Journal Articles

Immune Privileged Features of Multipotent Mesenchymal Stromal Cells Are Lost after Co-Cultivation with Allogeneic Lymphocytes in Vitro

Nikolay M Kapranov, Yuliya O Davydova, Nataliya Petinati, PhD, Maria V Bakshinskayte, Irina V Galtseva, Nina I. Drize, PhD, Larisa A. Kuzmina, MD PhD, Elena N. Parovichnikova, MD PhD, Valeriy G Savchenko, PhD MD

Blood (2016) 128 (22): 5722.

https://doi.org/10.1182/blood.V128.22.5722.5722

Published: 2016

NARROW

Platelet-Associated Antibodies By Flow Cytometry in Adult Patients with Immune Thrombocytopenia before and after Splenectomy

Oligoclonal Expansion and T-Cells Subpopulations in Patients with Aplastic Anemia at Different Stages of the Disease

The Effectiveness of Eltrombopag at the Different Stages of Aplastic Anemia and Probability of Clonal Expansion

Different Treatment Regimens, Optimal Time Points and Threshold Level While Minimal Residual Disease Evaluation in AML Patients

The MRD-Negativity Rate Measured By Flow Cytometry after the 1 st and the 2 nd Induction Course Among CR AML Patients from Different Cytogenetic Subgroups Does Not Differ Though the Morphological CR Achievement Does

Effective and Ineffective Samples of Mesenchymal Multipotent Stromal Cells Used for Acute Graft-Versus-Host Disease Prophylaxis after Allogeneic Bone Marrow Transplantation Differ in the Expression Level of HLA-DR When Co-Cultured with Activated Lymphocytes

Immune Privileged Features of Multipotent Mesenchymal Stromal Cells Are Lost after Co-Cultivation with Allogeneic Lymphocytes in Vitro

Email alerts

ASH Publications

American Society of Hematology

Platelet-Associated Antibodies By Flow Cytometry in Adult Patients with Immune Thrombocytopenia before and after Splenectomy

Oligoclonal Expansion and T-Cells Subpopulations in Patients with Aplastic Anemia at Different Stages of the Disease

The Effectiveness of Eltrombopag at the Different Stages of Aplastic Anemia and Probability of Clonal Expansion

Different Treatment Regimens, Optimal Time Points and Threshold Level While Minimal Residual Disease Evaluation in AML Patients

The MRD-Negativity Rate Measured By Flow Cytometry after the 1 st and the 2 nd Induction Course Among CR AML Patients from Different Cytogenetic Subgroups Does Not Differ Though the Morphological CR Achievement Does

Effective and Ineffective Samples of Mesenchymal Multipotent Stromal Cells Used for Acute Graft-Versus-Host Disease Prophylaxis after Allogeneic Bone Marrow Transplantation Differ in the Expression Level of HLA-DR When Co-Cultured with Activated Lymphocytes

Immune Privileged Features of Multipotent Mesenchymal Stromal Cells Are Lost after Co-Cultivation with Allogeneic Lymphocytes in Vitro

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only